Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

63
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
63
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.1K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

74
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
74
Introduction to Hemostasis01:05

Introduction to Hemostasis

10.5K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
10.5K
Disorders of Hemostasis01:24

Disorders of Hemostasis

1.5K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.5K
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

85
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
85

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preventing Post-induction Hypotension During General Anaesthesia: A Dose-Response Study of Ringer's Lactate Guided by the Inferior Vena Cava Collapsibility Index.

Cureus·2026
Same author

H3K27M-altered diffuse midline glioma: Experience and outcomes from a low-middle income country setting in the contemporary era.

Neuro-oncology advances·2026
Same author

Cost-Utility Analysis of Indocyanine Green Versus Methylene Blue for Sentinel Lymph Node Biopsy in Breast Cancer.

Journal of surgical oncology·2026
Same author

B(C<sub>6</sub>F<sub>5</sub>)<sub>3</sub>-Catalyzed Chemical Tagging of Bioactive <i>N</i>-Alkylamines through β-Amino C(sp<sup>3</sup>)-H Functionalization.

Organic letters·2026
Same author

Hand Deserve Better: global clinical consensus recommendations on surgical gloving practice.

The Journal of hospital infection·2026
Same author

Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Related Experiment Video

Updated: Nov 1, 2025

Application of Hemostatic Devices in Laparoscopic Hepatectomy
04:23

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Published on: April 19, 2022

2.5K

The Use of Hemostatic Agents to Decrease Bleeding Complications in Breast Cancer Surgery.

Joshua A Bloom1, Sina Foroutanjazi2, Zachary Erlichman2

  • 1Department of Surgery, 1867Tufts Medical Center, Boston, MA, USA.

The American Surgeon
|June 28, 2021
PubMed
Summary
This summary is machine-generated.

Hemostatic agents reduce bleeding complications and shorten Jackson-Pratt (JP) drain duration after breast cancer surgery. This study found agents decreased complications and drain use, particularly combination powder (CP).

Keywords:
hematomahemostatic agentmastectomyoncoplasticsseroma

More Related Videos

A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma
04:20

A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma

Published on: July 28, 2020

5.4K
A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine
08:27

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine

Published on: December 6, 2024

446

Related Experiment Videos

Last Updated: Nov 1, 2025

Application of Hemostatic Devices in Laparoscopic Hepatectomy
04:23

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Published on: April 19, 2022

2.5K
A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma
04:20

A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma

Published on: July 28, 2020

5.4K
A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine
08:27

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine

Published on: December 6, 2024

446

Area of Science:

  • Oncologic surgery
  • Surgical hemostasis

Background:

  • Adjuvant radiation and chemotherapy are common after breast cancer surgery.
  • Postoperative complications can delay necessary adjuvant therapies.
  • Hemostatic agents are potential tools to mitigate these complications.

Purpose of the Study:

  • To evaluate the impact of hemostatic agents on postoperative bleeding complications.
  • To assess the effect of hemostatic agents on Jackson-Pratt (JP) drain duration in oncologic breast surgery.

Main Methods:

  • Retrospective chart review of patients undergoing oncoplastic breast surgery or mastectomy with reconstruction.
  • Comparison of outcomes with no hemostatic agent, fibrin sealant (FS), and combination powder (CP).
  • Data collected included surgical type, hemostatic agent used, drain removal time, and postoperative complications (seroma, hematoma, OR takeback).

Main Results:

  • Hemostatic agent use was associated with fewer bleeding complications.
  • Significantly decreased time to JP drain removal was observed with hemostatic agent use.
  • Combination powder (CP) showed a trend towards greater reduction in drain duration compared to fibrin sealant (FS).

Conclusions:

  • Hemostatic agents can decrease postoperative complications in oncologic breast surgery.
  • The use of hemostatic agents significantly reduces the duration of JP drain use.
  • Combination powder (CP) may offer enhanced benefits in reducing drain duration.